CompletedNot Applicable

This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication

361 participantsStarted 2013-01-01

Plain-language summary

The goal of this observational study is to learn about the effects of psychiatric drug therapies on intra- and extra-oral sicca symptoms and salivation. The main question that it aims to answer is: Does taking psychiatric medication cause oral dryness and/or any changes on whole and minor saliva secretion? Participants taking psychiatric medication answered a 16-question questionnare, and their saliva production was measured by Periotron device and by spitting method.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: In the psychiatric group, the inclusion criteria was taking specific psychiatric medications. Exclusion Criteria: In the control group the exclusion criteria was reporting any diseases and taking medicines.

What they're measuring

Unstimulated whole saliva flow rate (UWS)

Timeframe: through study completion, an average of 1 year

Minor salivary gland (MSG) secretions

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT06920472

SponsorSemmelweis University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-01-01

View on ClinicalTrials.gov More Psychiatric Disorders trials